Atlas Trials

Drug-Drug Interaction Study Between EDP-514, Itraconazole, Carbamazepine, and Quinidine in Healthy Subjects

Clinical trial NCT04783753 · COMPLETED

Trial details

NCT number
NCT04783753
Sponsor
Enanta Pharmaceuticals, Inc
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Hepatitis B
Start date
2020-11-05
Primary completion
2021-06-28
Enrollment
72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.